Home » AstraZeneca Mulls Vaccine Sale After $12.5bn MedImmune Deal
AstraZeneca Mulls Vaccine Sale After $12.5bn MedImmune Deal
AstraZeneca is already
considering offloading MedImmune's vaccines business, just days after it paid
$15.2bn (£7.6bn, E11.2bn) for the US biotech.
The
Business
KEYWORDS Deals
Upcoming Events
-
07May
-
14May
-
30May